# JUR-003

Source: https://onco.cc/drugs/jur-003/  
OnCo record `jur-003` (Treatment). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

JUR-003 is an experimental biologic from Juri Biosciences, in phase 1 trials for metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer and oligometastatic prostate cancer.

## Summary

JUR-003 is a biologic (T-cell engager per OnCo text; registry says only 'Biological') from Juri Biosciences, with EpimAb Biotherapeutics as partner. A biologic given intravenously in a first-in-human phase 1a/1b study in prostate cancer. Its furthest stage is phase 1, for metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer and oligometastatic prostate cancer. ClinicalTrials.gov registers it in one study linked below. Phase 1a/1b NCT07824349 recruiting (registry, first posted 17 Sep 2026). Whether it works in people has not been established unless a trial below reports it.

## Fields

- Kind: Treatment
- Status: phase-1
- Last checked: 2026-11-03
- Tags: pipeline; ctgov-ingest
- Code: JUR-003
- Modality: Biologic (T-cell engager per OnCo text; registry says only 'Biological')
- Mechanism: A biologic given intravenously in a first-in-human phase 1a/1b study in prostate cancer.

## Sources

- Juri Biosciences: clinicaltrials.gov: https://clinicaltrials.gov/api/v2/studies/NCT07824349
- Juri Biosciences: clinicaltrials.gov: https://clinicaltrials.gov/api/v2/studies/NCT07824349
- Juri Biosciences: markets.financialcontent.com: https://markets.financialcontent.com/wral/article/gnwcq-2025-5-27-juri-biosciences-a-tcg-labs-soleil-portfolio-company-and-epimab-biotherapeutics-enter-into-a-worldwide-licensing-agreement-for-klk2-directed-t-cell-engager-in-metastatic-prostate-cancer
- ClinicalTrials.gov: trials of JUR-003: https://clinicaltrials.gov/search?intr=JUR-003

## Connected records

- cancers: [Metastatic castration-resistant prostate cancer](https://onco.cc/cancers/prostate-mcrpc/), [Metastatic hormone-sensitive prostate cancer](https://onco.cc/cancers/prostate-mhspc/), [Prostate cancer](https://onco.cc/cancers/prostate/)
- companies: [Juri Biosciences](https://onco.cc/companies/juri-biosciences/)
- trials: [JUR-003 in Adult Patients With Metastatic Prostate Cancer](https://onco.cc/trials/nct07824349/)

---
JSON: https://onco.cc/api/v1/entities/jur-003.json